Refine by
Coronary Disease Suppliers & Manufacturers
66 companies found
based inWayne, PENNSYLVANIA (USA)
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our ...
Coronary Artery Bypass Graft Surgery or CABG is a procedure used to treat coronary artery disease – the narrowing or blockage of the blood vessels that supply oxygen and nutrients to the heart ...
based inBonn, GERMANY
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The ...
Unmatched XLIMUS clinical performance. The ultimate DES for complex artery lesions. XLIMUS is considered as the ultimate coronary DES stent system to treat complex coronary artery disease by ...
based inIllkirch-Graffenstaden, FRANCE
Emosis develops and provides physicians with first-in-class, on demand, and user-friendly extended in vitro diagnostic products, centered on lab assay kits to be routinely performed on the rapidly growing new generation of flow cytometers, including ...
based inNew Taipei City, TAIWAN
ACME Dynacardia is a partnership between ACME Portable and Dynacardia. With over 23 years of experience, ACME Portable specializes in manufacturing and building high-performance, unique computers that are customized specifically for special ...
It is a patented algorithm that analyzes 10 second 12 lead ECG captured by either our own QED 2000 or a certified off-the-shelf ECG machine, and it aims to assist in detection of myocardial ischemia related to Coronary Artery ...
based inSan Diego, CALIFORNIA (USA)
Everyone at AnaBios shares a passion and commitment to make a difference in the development of promising new therapies and cures for patients by reducing the time and expense needed to bring these medicines to patients. We do this by generating ...
The human heart is a complex organ of distinct sub-structures, different tissue types and cellular architectures that work in a coordinated fashion to pump blood throughout the body (Figure 1). Tissue distribution, cellular composition and gene ...
based inChampionsGate, FLORIDA (USA)
Our purpose is to improve health of the patients all around the world with our strong, hardworking, dedicated and clinically driven biomedical solutions team. Our products and technologies are mostly focused on endovascular treatment solutions with ...
Atlas? is a coronary balloon-expandable Stainless Steel stent system consisting of everolimus particles. It is indicated for de novo and in-stent restenotic lesions in patients with coronary artery ...
based inCarlsbad, CALIFORNIA (USA)
CeloNova BioSciences, Inc. is developer and manufacturer of a portfolio of novel surfaced coated technologies, including the proprietary Polyzene-F nanocoating. This next-generation nanocoating is the result of years of rigorous scientific research ...
Our proprietary COBRA SG drug-coated PTCA balloon includes a bio-active medical coating designed to improve adhesion of organic and inorganic substrates and optimize drug delivery. Developed at a leading, international medical university, the novel ...
based inHorsholm, DENMARK
At TannerMedico A/S, our aim is to help you sleep comfortable, breathe easier and live healthier. We truly believe that any good treatment aims at killing the cause and not just the symptoms. We are a Scandinavian company with the corporate ...
based inRedondo Beach, CALIFORNIA (USA)
Quantimetrix designs, develops, and manufactures laboratory quality products at our headquarters in Redondo Beach, California. We are leaders in the field of liquid-stable quality control products, having pioneered these innovations more than 40 ...
based inSanta Clara, CALIFORNIA (USA)
Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic ...
Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™* for treatment of refractory angina and the Tiara™ System* for treatment of mitral valve ...
based inSalt Lake City,, UTAH (USA)
Alucent Biomedical is a privately held biomedical company focused on our vision to transform the way vascular disease is treated. We are focused on using advanced technology to harness the body’s own natural physiologic processes and structures. ...
The Alucent NVS Vessel Restoration System is designed to create a natural, stent-like scaffold using the body’s own tissue and processes. An all-in-one, integrated procedural system, Alucent NVS combines standard angioplasty techniques with a ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Response Biomedical has a global distribution network and is focused on enabling our strong network of partners to be leaders in their markets by providing exceptional levels of service and support. Response Biomedical fosters a values-based ...
Response Biomedical offers a FDA cleared whole blood immunoassay NT-proBNP test, with our proprietary RAMP technology which detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure around the ...
based inMalvern, PENNSYLVANIA (USA)
Shifa Biomedical Corporation (Shifa) is a drug discovery company in Malvern Pennsylvania. It is a privately held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease. ...
based inNeve Ilan, ISRAEL
We have developed a digital X-ray source enabling a cost reduction of medical imaging systems by orders of magnitude. We are a global company planning mass deployment of imaging systems. Our goal is to drive early detection preventive healthcare as ...
Healthcare providers and payers can now benefit from AI medical imaging technology to screen for early signs of chronic disease in large populations. Nanox Ai enables more accurate risk-adjustment so patients are provided with preventative care ...
based inDurham, NORTH CAROLINA (USA)
Tryton Medical is a leading developer of novel stent systems for the treatment of bifurcation lesions. The co-founders of the company, Aaron V. Kaplan M.D. and H. Richard Davis, recognized an unmet need in coronary artery disease treatment. ...
based inSan Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
ALDURAZYME (laronidase) is indicated for patients with Hurler and Hurler-Scheie forms of mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms. The risks and benefits of treating mildly affected ...
based inLivermore, CALIFORNIA (USA)
Advanced Bifurcation Systems has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology. The ABS platform is protected by more than 36 ...
based inWuxi, CHINA
CHISON Medical Technologies Co., LTD has emerged as World’s leading Diagnostic Ultrasound manufacturer since its inception in 1996. In the journey of constant development and revolution in technologies, CHISON has set its foot independently with ...
A revolutionary invention with everything you can imagine makes you more ...
based inSan Diego, CALIFORNIA (USA)
CureMetrix is committed to the advancement of technology that will improve cancer survival rates worldwide. Our research is focused on leveraging artificial intelligence and deep learning to develop the next generation of medical image analysis ...
cmAngio An investigational AI-based triage software that helps doctors assess a patient’s risk of coronary heart disease ...
based inSingapore, SINGAPORE
For more than 25 years, the Biosensors International Group (“Biosensors”) has been developing and marketing critical care catheter systems and related devices used during heart surgery and intensive care treatment. Continually striving to be at the ...
In Evidence Based Medicine We Trust: At Biosensors International, innovation and clinical evidence is our driving force. We don’t just bring innovative and unique coronary stents to the market, we conduct robust landmark clinical trials to ...
